Skip to content

Vertex Pharmaceuticals

US · VRTX #155 by market cap Listed 1970
515.02 -5.64 -1.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Improving
4
■ Upgrades■ Downgrades
  • 4 upgrades vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Maxim Group moved from Hold to Buy on 2026-03-18.

Analyst consensus 21 analysts

Buy
Avg price target 626.06 +21.6%
Price target rangecurrent 515.02
Low563.00
Avg626.06
High725.00
Buy 95% Hold 5% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-04 UBS -- Buy 640.00
2026-11-04 Maxim Group -- Buy 620.00
2026-11-04 H.C. Wainwright -- Buy 641.00
2026-11-04 Barclays -- Buy 626.00
2026-11-03 TD Cowen -- Buy 575.00
2026-11-03 UBS -- Buy 640.00
2026-11-03 Maxim Group -- Buy 620.00
2026-11-03 Scotiabank -- Buy 660.00
2026-11-03 Morgan Stanley -- Buy 660.00
2026-11-03 Stifel -- Hold 563.00
2026-11-03 BMO Capital -- Buy 620.00
2026-11-03 Citi -- Buy 585.00
2026-11-03 Goldman Sachs -- Buy 725.00
2026-11-03 H.C. Wainwright -- Buy 641.00
2026-11-03 J.P. Morgan -- Buy 570.00
2026-11-02 Cantor Fitzgerald -- Buy 619.00
2026-11-02 Wells Fargo -- Buy 650.00
2026-11-02 UBS -- Buy 615.00
2026-11-02 BofA Securities -- Buy 667.00
2026-11-02 Citi -- Buy 585.00
2026-11-02 RBC Capital -- Buy 600.00
2026-10-27 Citi -- Buy 585.00
2026-10-27 Leerink Partners -- Buy --
2026-10-26 TD Cowen -- Buy 550.00
2026-10-26 UBS -- Buy 615.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-03-18 Maxim Group Hold → Buy 575.00
2026-01-22 RBC Capital Hold → Buy 546.00
2026-01-12 Bernstein Hold → Buy --
2025-12-03 Morgan Stanley Hold → Buy 516.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-02 After close ±5.41% -4.05% (in line)
2026/Q2 2026-08-03 After close ±5.68% +1.70% (in line)
2026/Q1 2026-05-04 After close ±5.98% -1.28% (in line)
2025/Q4 2026-02-12 After close ±8.09% +5.69% (in line)
2025/Q3 2025-11-03 After close ±6.88% -1.02% (in line)
2025/Q2 2025-08-04 After close ±6.72% -20.60% (beat)
2025/Q1 2025-05-05 After close ±4.62% -10.03% (beat)
2024/Q4 2025-02-10 After close ±4.80% -3.14% (in line)
2024/Q3 2024-11-04 After close ±5.30% +5.73% (beat)
2024/Q2 2024-08-01 After close ±5.13% -2.24% (in line)
2023/Q4 2024-02-05 After close ±4.66% -2.98% (in line)
2023/Q3 2023-11-06 After close ±3.97% -1.95% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.

Vertex Pharmaceuticals discussion 0 comments

Add a comment